Skip to main content

Advertisement

Log in

Intravenous Immunoglobulin Therapy for Refractory Interstitial Lung Disease Associated with Polymyositis/Dermatomyositis

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Interstitial lung disease (ILD) associated with polymyositis/dermatomyositis (ILD-PM/DM), including amyopathic dermatomyositis (ADM), is recognized as an important condition because it frequently causes death, despite intensive therapy with high-dose corticosteroid and immunosuppressive agents, such as cyclosporine A and cyclophosphamide. Intravenous immunoglobulin therapy (IVIG) has shown efficacy for myopathy associated with PM/DM, but its usefulness for ILD-PM/DM is unclear. This study was designed to investigate the efficacy of IVIG for refractory ILD-PM/DM. A review was made of medical charts of five patients (2 men and 3 women) who were treated with IVIG for refractory ILD-PM/DM resistant to high-dose corticosteroid and cyclosporine A and/or cyclophosphamide. One patient had acute ILD-PM and four patients had acute ILD-ADM. Of the five patients, one patient with ILD-PM and one patient with ILD-ADM survived. No adverse reactions were seen due to IVIG treatment. There were no critical differences in the clinical parameters and clinical courses between survivors and nonsurvivors. IVIG treatment is safe and could be an effective salvage therapy for refractory ILD-PM/DM in certain cases, suggesting that further controlled trials are worthwhile.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of 2 parts). N Engl J Med 292:344–347

    PubMed  CAS  Google Scholar 

  2. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of 2 parts). N Engl J Med 292:403–407

    PubMed  CAS  Google Scholar 

  3. Sontheimer RD (2002) Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 20:387–408. doi:10.1016/S0733-8635(02)00021-9

    Article  PubMed  Google Scholar 

  4. Euwer RL, Sontheimer RD (1993) Amyopathic dermatomyositis: a review. J Invest Dermatol 100:124S–127S. doi:10.1111/1523-1747.ep12356896

    Article  PubMed  CAS  Google Scholar 

  5. Kagen LJ (1995) Amyopathic dermatomyositis. Arch Dermatol 131:1458–1459. doi:10.1001/archderm.131.12.1458

    Article  PubMed  CAS  Google Scholar 

  6. Erel A, Toros P, Tokcaer AB, Gurer MA (2000) Amyopathic dermatomyositis. Int J Dermatol 39:771–773. doi:10.1046/j.1365-4362.2000.00047-5.x

    Article  PubMed  CAS  Google Scholar 

  7. Olsen NJ, Park JH, King LE Jr (2001) Amyopathic dermatomyositis. Curr Rheumatol Rep 3:346–351. doi:10.1007/s11926-001-0039-9

    Article  PubMed  CAS  Google Scholar 

  8. Caproni M, Cardinali C, Parodi A, Giomi B, Papini M, Vaccaro M, Marzano A, De Simone C, Fazio M, Rebora A, Fabbri P (2002) Amyopathic dermatomyositis: a review by the Italian Group of Immunodermatology. Arch Dermatol 138:23–27. doi:10.1001/archderm.138.1.23

    Article  PubMed  Google Scholar 

  9. Dalkas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971–982. doi:10.1016/S0140-6736(03)14368-1

    Article  Google Scholar 

  10. Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G (2004) Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 63:297–301. doi:10.1136/ard.2003.006122

    Article  PubMed  CAS  Google Scholar 

  11. Schnable A, Reuter M, Biederer J, Richter C, Gross WL (2003) Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 32:273–284. doi:10.1053/sarh.2002.50012

    Article  Google Scholar 

  12. Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF, Devulder B, Herson S, Levesque H, Courtois H (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47:614–622. doi:10.1002/art.10794

    Article  PubMed  CAS  Google Scholar 

  13. Hirakata M, Nagai S (2000) Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 12:501–508. doi:10.1097/00002281-200011000-00005

    Article  PubMed  CAS  Google Scholar 

  14. Takizawa H, Shiga J, Moroi Y, Miyachi S, Nishiwaki M, Miyamoto T (1987) Interstitial lung disease in dermatomyositis: clinicopathlogical study. J Rheumatol 14:102–107

    PubMed  CAS  Google Scholar 

  15. Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I (1999) Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Rheumatol 26:1527–1533

    PubMed  CAS  Google Scholar 

  16. Sontheimer RD, Miyagawa S (2003) Potentially fatal interstitial lung disease can occur in clinically amyopathic dermatomyositis. J Am Acad Dermatol 48:797–798. doi:10.1067/mjd.2003.199

    Article  PubMed  Google Scholar 

  17. Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M, Amano K, Takeuchi T (2005) Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 32:1719–1726

    PubMed  CAS  Google Scholar 

  18. Miyake S, Ohtani Y, Sawada M, Inase N, Miyazaki Y, Takano S, Miyasaka N, Yoshizawa Y (2002) Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis. Sarcoidosis Vasc Diffuse Lung Dis 19:128–133

    PubMed  Google Scholar 

  19. Dalkas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, Dinsmore ST, McCrosky S (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329:1993–2000. doi:10.1056/NEJM199312303292704

    Article  Google Scholar 

  20. Cherin P, Pelletier S, Teixeria P, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S (2002) Result and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum 46:467–474. doi:10.1002/art.10053

    Article  PubMed  CAS  Google Scholar 

  21. Danieli MG, Malcangi G, Palmieri C, Logullo F, Salvi A, Piani M, Danieli G (2002) Cyclosporine A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. Ann Rheum Dis 61:37–41. doi:10.1136/ard.61.1.37

    Article  PubMed  CAS  Google Scholar 

  22. Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T, Hashimoto D, Sato J, Toyoshima M, Hashizume H, Chida K (2006) Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 28:1005–1012. doi:10.1183/09031936.06.00038806

    Article  PubMed  CAS  Google Scholar 

  23. Miyazaki E, Ando M, Muramatsu T, Fukami T, Matsuno O, Nureki S, Ueno T, Tsuda T, Kumamoto T (2007) Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis. Clin Rheumatol 26:436–439. doi:10.1007/s10067-005-0147-4

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuzo Suzuki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, Y., Hayakawa, H., Miwa, S. et al. Intravenous Immunoglobulin Therapy for Refractory Interstitial Lung Disease Associated with Polymyositis/Dermatomyositis. Lung 187, 201–206 (2009). https://doi.org/10.1007/s00408-009-9146-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-009-9146-6

Keywords

Navigation